These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5823553)

  • 1. Primary pulmonary hypertension in a child. Response to pharmacologic agents.
    Satyanarayana Rao BN; Moller JH; Edwards JE
    Circulation; 1969 Oct; 40(4):583-7. PubMed ID: 5823553
    [No Abstract]   [Full Text] [Related]  

  • 2. The paradoxic effect of tolazoline hydrochloride on pulmonary hypertension of mitral stenosis.
    Yoran C; Glassman E
    Chest; 1973 May; 63(5):843-6. PubMed ID: 4703648
    [No Abstract]   [Full Text] [Related]  

  • 3. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S; Martinez J; Lam W; Levy PS; Rosen KM
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.
    Daoud FS; Reeves JT; Kelly DB
    Am J Cardiol; 1978 Nov; 42(5):817-22. PubMed ID: 707294
    [No Abstract]   [Full Text] [Related]  

  • 5. The reversibility of pulmonary hypertension in patients with cystic fibrosis. Observations on the effects of tolazoline hydrochloride.
    Kelminson LL; Cotton EK; Vogel JH
    Pediatrics; 1967 Jan; 39(1):24-35. PubMed ID: 6016228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of primary pulmonary hypertension].
    Both A
    Z Kreislaufforsch; 1970 Oct; 59(10):909-11. PubMed ID: 4992357
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary hypertension in lambs with congenital diaphragmatic hernia: vasodilator prostaglandins, isoprenaline, and tolazoline.
    Ford WD; Sen S; Barker AP; Lee CM
    J Pediatr Surg; 1990 May; 25(5):487-91. PubMed ID: 2352080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary pulmonary hypertension.
    Fishman AP; Pietra GG
    Annu Rev Med; 1980; 31():421-31. PubMed ID: 6994621
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary pulmonary hypertension in children].
    Lichtenstern-Peters E; Bein G; Lange L; Jimenez E; Schachinger H; Schartl S; Stoltenburg-Didinger G
    Z Kardiol; 1982 Nov; 71(11):779-83. PubMed ID: 7157932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxygen and tolazoline as vasodilators in pulmonary arterial hypertension secondary to high pulmonary blood flow].
    Salgado-Escobar JL; Ledesma-Velasco M; Munayer-Calderón J; Núñez-Garduño D; Salas-López ME; Rodríguez-Hernández L
    Bol Med Hosp Infant Mex; 1987 Mar; 44(3):137-42. PubMed ID: 3580096
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactive pulmonary arterial hypertension after pulmonary venous constriction in the calf.
    Silove ED; Tavernor WD; Berry CL
    Cardiovasc Res; 1972 Jan; 6(1):36-44. PubMed ID: 5014277
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of ATP-MgCl2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects.
    Brook MM; Fineman JR; Bolinger AM; Wong AF; Heymann MA; Soifer SJ
    Circulation; 1994 Sep; 90(3):1287-93. PubMed ID: 8087937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Hermiller JB; Bambach D; Thompson MJ; Huss P; Fontana ME; Magorien RD; Unverferth DV; Leier CV
    Ann Intern Med; 1982 Oct; 97(4):480-9. PubMed ID: 7125407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary pulmonary hypertension; favorable effect of isoproterenol.
    Shettigar UR; Hultgren HN; Specter M; Martin R; Davies DH
    N Engl J Med; 1976 Dec; 295(25):1414-5. PubMed ID: 980096
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the haemodynamic effects of epoprostenol (prostacyclin) and tolazoline.
    Bush A; Busst CM; Knight WB; Shinebourne EA
    Br Heart J; 1988 Aug; 60(2):141-8. PubMed ID: 3046646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of local vasodilatation on blood flow through arterial stenosis. A theoretical analysis of the pressure-flow dynamics.
    Kreuzer W; Schenk WG
    Eur Surg Res; 1973; 5(3):233-42. PubMed ID: 4748905
    [No Abstract]   [Full Text] [Related]  

  • 17. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension.
    Drummond WH; Gregory GA; Heymann MA; Phibbs RA
    J Pediatr; 1981 Apr; 98(4):603-11. PubMed ID: 6782220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of canine pulmonary hypertension: effects of norepinephrine and isoproterenol on pulmonary vascular pressure-flow characteristics.
    Ducas J; Duval D; Dasilva H; Boiteau P; Prewitt RM
    Circulation; 1987 Jan; 75(1):235-42. PubMed ID: 3791605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.
    Kulik TJ; Lock JE
    Clin Perinatol; 1984 Oct; 11(3):693-701. PubMed ID: 6488673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A problem in pulmonary hypertension. 1. The clinical course. A clinicopathologic conference from the Division of Pulmonary Diseases, Hahnemann Medical College and Hospital, Philadelphia.
    Chest; 1974 Jan; 65(1):69-75 contd. PubMed ID: 4809335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.